Milenia Biotec GmbH, a Germany-based company founded in 2000, has become a prominent player in the biotechnology sector by specializing in the production of lateral flow rapid tests. Utilizing the slogan "Lateral Flow Rapid Tests and more", they serve diverse domains such as medicine, food diagnostics, and research.
Their flagship product, Milenia HybriDetect, empowers users to develop customized point-of-care tests. Since its inception, millions of test strips have been produced, facilitating developments in diagnostics across diverse fields including the identification of bacteria, viruses, species, and gene mutations. This has led to over 100 scientific publications citing the product.
Despite lacking recent investment records, Milenia Biotec demonstrates a strong market presence with a versatile product range that includes PCR kits and tests for diagnosing inflammatory diseases. Their robust operational base in Gießen, Germany, ensures supply readiness for global clients, indicating strong potential for interested investors.